Eargo Closes First Tranche Investment of $100 Million from Patient Square Capital

SAN JOSE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq:EAR) (the “Company”), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced it has completed the issuance of $100 million aggregate principal amount of senior secured convertible notes to Patient Square Capital on June 28, 2022 (the “First Tranche Investment”).